Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Appoints Chief Scientific Officer, Rounds-out Industry Leading Management Team

October 28, 2019 11:21:26
  • PLUS recently appointed a respected researcher, Dr. Ari Mackler, as its chief scientific officer to oversee the company’s research and education efforts
  • The company’s CEO believes that Mackler will play an invaluable role in PLUS’ forward operations, positioning it among industry thought leaders
  • The new CSO joins a proven team of professionals, including former CPG executives, chefs, chemists and food-manufacturing experts

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis-branded product company with the two best-selling cannabis products in California, is committed to careful, deliberate product research, formulation and delivery. As part of the company’s strategic plan to strengthen its reputable brand, PLUS has named its first-ever chief scientific officer, Dr. Ari Mackler (

With 20 years of medical affairs, communications, and research experience in pharmaceutical, healthcare, and consumer goods industries, Mackler brings with him an impressive list of accomplishments and valuable professional experience.

“I have been intrigued by cannabis for years and saw a huge opportunity to apply my scientific and consumer products background for PLUS to help validate and articulate how their products may help people live better lives,” Mackler, who most recently was vice president of clinical development for the Wonderful Company, stated in a news release. “I also believe scientifically based education is vital to the future of the industry, and PLUS has focused their business processes in a way that ensures science is at the center of their product development DNA.”

Adding Mackler to the PLUS team represents the company’s deep commitment to intentional product development and offerings. “Dr. Mackler has a long history of helping consumer product companies share a clear and scientifically backed narrative around product benefits,” PLUS co-founder and CEO Jake Heimark stated in a news release. “Cannabis is a performance category, and the most successful brands will be those that understand and are able to clearly communicate why their products work. There are few researchers of Dr. Mackler’s caliber in the cannabis industry today, and we believe he will play an invaluable role not only for PLUS but as a thought leader within the industry.”

At the Wonderful Company, Mackler oversaw company health and wellness initiatives and was integrally involved in efforts to help the business become a global branded-products leader. He has also held positions with the multinational pharmaceutical company Merck & Co, the Almond Board of California, the International Tree Nut Council, the Nutritional Research & Education Foundation, and Stem Cell Resource.

At PLUS, Mackler will focus on establishing research relationships and clinical trials with academic institutions and private partners. These partnerships will be aimed at growing and strengthening consumer understanding of cannabis and its benefits. Mackler joins Plus Products’ outstanding product team of professionals, which includes Michelin-star sous chefs, chemists, and food-manufacturing experts.

Plus Product’s purposeful approach to product development and its expert team have already established a successful track record. The company currently boasts two of the top-selling cannabis products in California: Restore – Indica Blackberry Lemon Gummies (20 pack) and Sour Watermelon Gummies (20 pack).

PLUS cannabis-infused edibles are available in more than 360 licensed retailers across the state of California, and the company recently launched its products in Nevada, one of the nation’s most promising cannabis markets. In addition, PLUS unveiled a line of 100 percent hemp-CBD-infused gummies, available on its website.

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office